ILMN

#489
Illumina Inc
134.46
+11.32%
Secteur:
Base:
Devise de Profit:
Range quotidien
134.46
134.46
Range Annuel
68.70
155.47
Changement quotidien
+11.32%
Changement Mensuel
-11.28%
Evolution sur 6 mois
+34.82%
Changement Annuel
+52.78%
Clôture Précédente
120.79
Open
134.46
Bid
Ask
Low
134.46
High
134.46
Volume
425
Open full chart

Financials

Overview Relevé Statistics Dividends
Quarterly Annual
  • Market Capitalization 20.84 B
  • Employee 8 650
  • Founded 1998
  • CEO Jacob Thaysen
  • Website www.illumina.com
  • Headquarter Delaware, United States
  • FIGI BBG000DSMS70
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
24.68
Price to sales ratio
4.83
Dividends per share
—
Dividend yield %
—

Illumina Inc

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries. Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies.

Nouvelles